Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Global Bioenergies: €20m Capital Raise To Fund Second Phase Of Pilot

By Edison Stock MarketsJul 05, 2013 05:59AM ET
www.investing.com/analysis/global-bioenergies:--%EF%BF%BD%EF%BF%BD%EF%BF%BD20m-capital-raise-to-fund-second-phase-of-pilot-174334
Global Bioenergies: €20m Capital Raise To Fund Second Phase Of Pilot
By Edison   |  Jul 05, 2013 05:59AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
Capital raising launched for industrial pilot
Global Bioenergies (GBE) has announced funding for the two stages of industrial pilot testing of its proprietary process for producing isobutene from renewable sources. On top of a proposed €20m capital increase it will receive €4m from French state sources, out of a €5.2m package, in alliance with Arkema and the Centre National de la Recherche Scientifique (CNRS). The capital increase will cover the remaining cost of the first pilot, plus the estimated €15m capex requirement for the second pilot. Management is currently exploring prospective sites and industrial partners for the second pilot, with more details expected to be announced in H114.
Global
Global

State funding for the first industrial pilot
GBE has announced that the industrial pilot for its isobutene process will be partly funded by €5.2m of state funding under the Investissements d’Avenir programme managed by the Commissariat General a l’Investissement. GBE will receive €4m of the total state funding over three years, a third of which will be in the form of subsidies, two-thirds as loans. The industrial pilot phase is due to start in July, after the success of laboratory testing, during which the performance of the process has been improved and a larger lab pilot installed to start the industrialisation phase.

€20m capital raise to fund second phase of pilot
GBE has launched a proposed €20m capital increase, running from 27 June to 9 July, priced at €24.8, a 19% discount to the last month’s weighted average price. This could be increased by 15% to €23m if there is demand. The offer has already received confirmed subscriptions of €13m from new and existing investors, including four private equity entities of a French bank, which are dedicated to innovative companies. The offer is open to institutional and French retail investors.

Valuation: Our valuation range remains €58-85m
This development does not change our €69m mid-point valuation within a €58-85m range, which is based on a DCF, using the isobutene process as a proxy for the value of the whole company and excluding the processes for the other olefins, as they are at a much earlier stage of development. Our range incorporates a variety of sensitivities and probability adjusted cash flows around a base case discount rate of 16%. We have not focused on relative valuations, as there are no direct comparative companies and traditional valuation metrics are not particularly useful, given GBE’s current lack of profitability.

To Read the Entire Report Please Click on the pdf File Below.
Global Bioenergies: €20m Capital Raise To Fund Second Phase Of Pilot
 

Related Articles

Global Bioenergies: €20m Capital Raise To Fund Second Phase Of Pilot

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email